J&J could really expedite the process, and even bring the manufacturing fire-power to get this into the market and solve any CMC concerns the FDA may now have. But I'd like to also keep Catalent as a source.
I feel like I'm trying to knit a winter sweater out of spiderwebs. I hope we hear some news about a business partnership soon. Maybe news with our Q3 10-Q?
Market Data 
Markets 
AI
